Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs

NCT02215122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
COPD

Interventions

DRUG: MGR001
DRUG: Advair® Diskus®
DRUG: Seretide™ Accuhaler™

Sponsor

Mylan Pharma UK Ltd.